Dr. Scott Rocklage: Helping Early-Stage Life-Science Entrepreneurs Through 3AM Ventures

Venture capital firm 5AM Venture managing partner Dr. Scott Rocklage isn’t afraid to be involved in measured risk-taking. He has long been involved in cutting–edge medical research and the development of innovative drugs and medicines. He has helped the drugs Teslascan, Cubicin and Omniscan to get FDA approval, gotten several others into clinical trials and works with researchers, physician and entrepreneurs every day to turn their ideas into medicines, treatments and medical technologies to increase the length and quality of people’s lives.


For 30 years, since earning his BA in chemistry from UC Berkley and a chemistry PhD from MIT, Dr. Scott Rocklage has held executive positions with a wide range of biomedical companies, gained healthcare management experience and had strategic leadership responsibilities. He also over two dozens U.S. patents and his writings have appeared in more than 100 peer-reviewed scientific journals. He is a perfect fit for 5AM Ventures. There he can identify life science companies with viable ideas and get them the financial support and guidance they need to succeed.


Prior to becoming a venture partner at 5AM Ventures in 2003, Dr. Scott Rocklage was executive or board member with Cubist Pharmaceuticals, Nycomed Salutar, Relypsa, Novira, Semprus, Miikana and Ilypsa. He was also involved in research and development with Salutar, Catalytica and many others. Dr. Rocklage is currently on the chairman of the board at Cidara, Kinestral, Rennovia, Epirus and Pulmatrix. He also shared a lab with Nobel Prize winner Richard R. Schrock at the Massachusetts Institute of Technology. His focus is now on early stage life science based companies and the viability of their products.


Based in 5AM Ventures’ Boston, Massachusetts office, Dr. Scott Rocklage spends his days focused on life science, working with the portfolio management team and attending board meetings. He closely monitors the explosive growth in unique, targeted cancer treatments. Dr. Rocklage is excited about the medical developments he sees taking place in the near future. Known for being very well organized and a master of time management and prioritization, Dr. Rocklage also knows how important it is for new companies to have the right people on their staff and can share that with the companies in which 5AM Ventures invests.


Dr. Rocklage can help early stage companies to understand how important it is to stay true to what they do well and not stray away from their strengths and they can succeed.


Connect with Dr. Scott Rocklage on LinkedIn.

Leave a Reply

Your email address will not be published. Required fields are marked *